Tag: life sciences
-
Illumina Partnering with IBM, Phillips on Genomics Tools
Genomics technology company Illumina Inc. is collaborating with technology enterprises IBM and Royal Phillips to expand its sequencing services in precision medicine for cancer.
-
Sanofi Licensing Antibody for Autoimmune Diseases
The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College.
-
Ionis Options Cardiac Drugs in $1.5 Billion Deal
Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease.
-
Precision Health Tech Network Expands, Invests $400M
Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network.
-
Technique Uses Light to Activate Drugs in Blood Cells
A pharmacology lab developed a process that directs light waves at circulating blood cells to release drugs stored in those cells at precise times and locations.
-
Gene Expression Changes Found in Wound Healing Therapy
A clinical trial to reveal the mechanism of a cell therapy to treat venous skin ulcers found the therapy works by altering the gene expression activity of treated cells to resemble healthy tissue.
-
Biotech, Pharma Partner on Neuro Drug Discovery
A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders.
-
Antibody Trials Stopped After Deaths Reported
The U.S. Food and Drug Administration halted early-stage clinical trials of a monoclonal antibody drug for leukemia after four deaths occurred from liver toxicity.
-
Trial to Test Stem Cells for Treating Heart Failure
A clinical trial testing a treatment for heart failure using a patient’s own bone marrow stem cells is recruiting participants at the first two study sites.
-
Brain Cancer Regression Shown with Engineered T-Cells
A patient treated with immune system cells genetically modified to attack his brain cancer reported regression of recurring tumors in the brain and spinal cord.